Immunopeptidomics-guided identification of functional neoantigens in non-small cell lung cancer

Ben Nicholas, Alistair Bailey, Katy J. McCann, Oliver Wood, Eve Currall, Peter Johnson, Tim Elliott, Christian Ottensmeier, Paul Skipp · 2026

Read Immunopeptidomics-guided identification of functional neoantigens in non-small cell lung cancer by Ben Nicholas, Alistair Bailey, Katy J. McCann, Oliver Wood, Eve Currall, Peter Johnson, Tim Elliott, Christian Ottensmeier, Paul Skipp (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13601597.txt.

Description

Ben Nicholas leads a nine-author team hunting better vaccine targets for lung cancer in 2026. Personalized vaccines can aim at neoantigens, protein fragments created by tumor mutations, but standard hunting methods yield candidates that work only about 6 percent of the time. Non-small cell lung cancer still kills most patients within a few years, so targeting matters. The team worked with samples from 24 patients, most with adenocarcinoma and the rest with squamous cell carcinoma.

Their method read the peptides actually displayed on tumor cells by mass spectrometry, combining that with genome and gene-activity data. Candidates were filtered by what patients' immune systems demonstrably present. The payoff was large: five of six patients tested responded, and 13 percent of candidate neoantigens drew strong responses. Modeling also revealed patient-specific presentation patterns. Checking real display data rather than predicting alone, the authors argue, is what makes personalized lung cancer vaccines practical.

Catalog record

CREATORBen Nicholas, Alistair Bailey, Katy J. McCann, Oliver Wood, Eve Currall, Peter Johnson, Tim Elliott, Christian Ottensmeier, Paul Skipp
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73667
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13601597

Browse the full library · About the Tower of Babel